Hyperion Defi (HYPD) Shares Outstanding (2016 - 2026)
Hyperion Defi (HYPD) posted quarterly Shares Outstanding (Entity) of $11.4 million for Q1 2026, up 422.1% year-over-year from $2.2 million in Q1 2025, and down 77.92% quarter-over-quarter from $51.8 million in Q4 2025.
Hyperion Defi (HYPD) Shares Outstanding (2016 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Shares Outstanding (Entity) for 11 consecutive years, with $11.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 422.1% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (up 422.1% YoY), while the FY2025 annual figure was $51.8 million, up 6114.37% from the prior year.
- Shares Outstanding (Entity) fell to $11.4 million in Q1 2026 per HYPD's latest filing, from $51.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $51.8 million in Q4 2025 and bottomed at $396230.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $4.9 million across 5 years, with a median of $592329.0 in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) climbed 13.52% — and 2025, when it surged 6114.37%.
- Hyperion Defi's Shares Outstanding (Entity) stood at $458362.0 in 2022, then rose by 24.23% to $569413.0 in 2023, then jumped by 46.29% to $832997.0 in 2024, then soared by 6114.37% to $51.8 million in 2025, then tumbled by 77.92% to $11.4 million in 2026.
- Business Quant data shows HYPD's Shares Outstanding (Entity) at $11.4 million in Q1 2026, $51.8 million in Q4 2025, and $7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 14.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.61 Mn |
| Mar 31, 2026 | 10.61 Mn |
| Dec 31, 2025 | 51.77 Mn |
| Sep 30, 2025 | 6.03 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 832,997.00 |
| Sep 30, 2024 | 869,479.00 |
| Jun 30, 2024 | 664,022.00 |
| Mar 31, 2024 | 582,585.00 |
| Dec 31, 2023 | 512,912.00 |
| Sep 30, 2023 | 501,746.00 |
| Jun 30, 2023 | 476,173.00 |
| Mar 31, 2023 | 467,632.00 |
| Dec 31, 2022 | 420,622.00 |
| Sep 30, 2022 | 432,897.00 |
| Jun 30, 2022 | 420,561.00 |
| Mar 31, 2022 | 375,102.00 |
| Dec 31, 2021 | 329,051.00 |
| Sep 30, 2021 | 325,669.00 |